Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression in alveolar macrophages between bleomycin–treated wild-type and S1pr2-/- mice.

ABSTRACT: We compared mRNA expression in alveolar macrophages between bleomycin–treated wild-type and S1pr2-/- mice, using DNA microarray analysis. In S1pr2-/- macrophages, 398 genes showed decreases to less than 50% of the levels in wild-type macrophages. In contrast, 122 genes showed more than 2.0-fold increases in S1pr2-/- macrophages compared with wild-type macrophages. The downregulated genes in S1pr2-/- mice included the following potentially fibrosis–related genes: profibrotic cytokines, chemokines, and the markers characteristic of classically activated (M1) and alternatively activated (M2) macrophages.

ORGANISM(S): Mus musculus

PROVIDER: GSE85411 | GEO | 2018/05/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

S1PR2 Signaling in Chronic Glucocorticoid Exposure-Induced Metabolic Disorders

Project description:Glucocorticoids play a key role in metabolic adaptation during stress, such as fasting and starvation. Excess and/or chronic glucocorticoid exposure, however, cause metabolic disorders that include insulin resistance dyslipidemia and hepatic steatosis. We previously showed that chronic glucocorticoid treatment elevates hepatic production of ceramides and sphingosine-1-phosphate (S1P). Ceramides are converted to sphingosine that is further converted to S1P. We showed that ceramide-initiated signaling in turn inhibits insulin signaling and increases lipogenic program in hepatocytes. However, the role of S1P, a signaling molecule that modulates physiological responses through membrane S1P receptors (S1PRs), in glucocorticoid actions is unclear. Here we found that inhibiting S1PR2 activity, but not S1PR1 and S1PR3, resulted in improved glucocorticoid-induced insulin resistance. Similarly, reducing hepatic S1PR2 expression showed similar results. Interestingly, reducing S1PR2 expression did not affect the ability of glucocorticoids to modify insulin signaling. Instead, glucocorticoids enhanced gluconeogenesis was reduced. Moreover, glucocorticoid-induced dyslipidemia and fatty liver was also compromised in mice with reduced hepatic S1PR2 expression. Indeed, RNA sequencing analysis showed that lipogenic, gluconeogenic and glycolytic genes are significantly lower in glucocorticoid-treated hepatic S1PR2 knockdown mice than those of glucocorticoid-treated hepatic scramble small hairpin RNA (shRNA) expressing mice (Control). Overall, our studies highlight the importance role of S1PR2 signaling in the mediating glucocorticoid regulation on gluconeogenesis and hepatic lipid homeostasis.

2023-05-13 | GSE150626 | GEO

Spatial transcriptomics revealed that S1pr2 deletion in keratinocytes increases the MyD88/NF-kB pathway and psoriasis-related cytokine expression in the epidermis

Project description:The importance of the cross-talk between keratinocytes and immune cells in the pathogenesis of psoriasis has recently been reaffirmed. Recent studies have found that several S1PR functional antagonists, other than S1PR2, are effective in improving psoriasis. We performed spatial transcriptomics to map the immune cell landscape and its association with metabolic pathways in an imiquimod (IMQ)-induced psoriasis-like inflammation in S1pr2fl/fl K14-Cre mice that could not sense sphingosine-1-phosphate (S1P) in the epidermis through the S1PR2 receptor. Our analysis suggests that S1PR2 in keratinocytes plays a major role in psoriasis-like inflammation compared to other S1PRs. It acts as a down-regulator, inhibiting the recruitment of Th17 cells into the skin.

2024-09-20 | GSE277246 | GEO

E-GEOD-35825

Project description:Type I and II Interferon-Stimulated Genes in Murine Primary Bone Marrow Macrophages

2015-09-28 | E-GEOD-35825 | ExpressionAtlas

Mus musculus

Project description:Gene expression in alveolar macrophages between bleomycin–treated wild-type and S1pr2-/- mice.

| PRJNA338392 | ENA

E-MTAB-8439

Project description:RNA-Seq profiling of ERCC1-XPF DNA repair defect (Er1F/-) versus wild type (Er1F/+) macrophages

2023-06-16 | E-MTAB-8439 | ExpressionAtlas

E-MTAB-5032

Project description:RNA-seq analysis of normoxic and hypoxic tumor-associated macrophages from wild type or REDD1 knockout mice

2019-05-14 | E-MTAB-5032 | ExpressionAtlas

E-MEXP-3623

Project description:Transcription profiling by array of peritoneal macrophages from B6 wild type and B6-Rag1 knock-out mice

2014-07-03 | E-MEXP-3623 | ExpressionAtlas

s1pr2

Project description:Danio rerio s1pr2, sphingosine-1-phosphate receptor 2 [Source:NCBI gene;Acc:170457], is differentially expressed in 1 experiment(s);

| ENSDARG00000036548 | ExpressionAtlas

S1PR2

Project description:Monodelphis domestica S1PR2, sphingosine-1-phosphate receptor 2 [Source:NCBI gene;Acc:100012444], is expressed in 2 baseline experiment(s);

| ENSMODG00000028318 | ExpressionAtlas

s1pr2

Project description:Danio rerio s1pr2, sphingosine-1-phosphate receptor 2 [Source:NCBI gene;Acc:170457], is expressed in 1 baseline experiment(s);

| ENSDARG00000036548 | ExpressionAtlas

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data